DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Jeff Collins to sit on a panel titled “Investing in Neurotech” at The Neurotech Industry Investing and Partnering Conference in Boston, MA
News | 05. 08. 2008
